These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19308684)

  • 1. Regulation of tumor progression by extracellular galectin-3.
    Nangia-Makker P; Balan V; Raz A
    Cancer Microenviron; 2008 Dec; 1(1):43-51. PubMed ID: 19308684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular functions of galectin-3.
    Ochieng J; Furtak V; Lukyanov P
    Glycoconj J; 2002; 19(7-9):527-35. PubMed ID: 14758076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 in angiogenesis and metastasis.
    Funasaka T; Raz A; Nangia-Makker P
    Glycobiology; 2014 Oct; 24(10):886-91. PubMed ID: 25138305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
    Nangia-Makker P; Raz T; Tait L; Hogan V; Fridman R; Raz A
    Cancer Res; 2007 Dec; 67(24):11760-8. PubMed ID: 18089806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the biological functions of galectin-3 by matrix metalloproteinases.
    Ochieng J; Green B; Evans S; James O; Warfield P
    Biochim Biophys Acta; 1998 Jan; 1379(1):97-106. PubMed ID: 9468337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling galectin-1 as a novel therapeutic target for cancer.
    Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
    Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of galectin-1 by extracellular matrix triggers T cell death.
    He J; Baum LG
    J Biol Chem; 2004 Feb; 279(6):4705-12. PubMed ID: 14617626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
    Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
    Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
    Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
    Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1.
    Cousin JM; Cloninger MJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
    Zhang X; Huang S; Guo J; Zhou L; You L; Zhang T; Zhao Y
    Int J Oncol; 2016 May; 48(5):1783-93. PubMed ID: 26892540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3: a potential target for cancer prevention.
    Ahmed H; Guha P; Kaptan E; Bandyopadhyaya G
    Trends Carbohydr Res; 2011; 3(2):13-22. PubMed ID: 25484547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer-associated carbohydrate-binding protein galectin-3 and its therapeutic ligands].
    Bai H; Liu L; Li YH; You Y; Mei QB
    Sheng Li Ke Xue Jin Zhan; 2008 Apr; 39(2):129-34. PubMed ID: 18664176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3.
    Ochieng J; Leite-Browning ML; Warfield P
    Biochem Biophys Res Commun; 1998 May; 246(3):788-91. PubMed ID: 9618290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells.
    Horiguchi N; Arimoto K; Mizutani A; Endo-Ichikawa Y; Nakada H; Taketani S
    J Biochem; 2003 Dec; 134(6):869-74. PubMed ID: 14769876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
    Matarrese P; Fusco O; Tinari N; Natoli C; Liu FT; Semeraro ML; Malorni W; Iacobelli S
    Int J Cancer; 2000 Feb; 85(4):545-54. PubMed ID: 10699929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogs of tetrahydroisoquinoline natural products that inhibit cell migration and target galectin-3 outside of its carbohydrate-binding site.
    Kahsai AW; Cui J; Kaniskan HU; Garner PP; Fenteany G
    J Biol Chem; 2008 Sep; 283(36):24534-45. PubMed ID: 18556657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 as a Potential Target to Prevent Cancer Metastasis.
    Ahmed H; AlSadek DM
    Clin Med Insights Oncol; 2015; 9():113-21. PubMed ID: 26640395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 and cancer (Review).
    Califice S; Castronovo V; Van Den Brûle F
    Int J Oncol; 2004 Oct; 25(4):983-92. PubMed ID: 15375548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.